Loading [MathJax]/jax/output/SVG/jax.js
Review

A compendium of single cell analysis in aging and disease

  • Received: 14 August 2019 Accepted: 25 March 2020 Published: 27 March 2020
  • Cell is the fundamental structural and functional unit of complex multicellular organisms. Conventional methods which involve average analysis of cells in bulk populations can undermine physiologically significant cell populations, whereas analysis of cells at a single cell level may reveal unique biomarkers and other mechanisms that govern the genotype and phenotype in various physiological processes in presumed homogenous cell populations. Cellular abnormalities such as irregularities in cellular mechanisms have been linked to human aging and other major diseases including neurodegenerative, vascular, autoimmune, and cancer. Aging is a functional decline associated with various diseases in an organism, majorly arising from cellular abnormalities. Single cell analysis (SCA) which involves isolation and study of single cell proteomics, genomics, transcriptomics and metabolomics which enables research of cellular abnormalities with a molecular resolution, is gaining recognition in the research of human aging and disease. The advances in SCA are producing breakthrough information about cellular heterogeneity, disease progression, cellular microenvironment and its interactions, early diagnostics, improving precision medicine through high throughput drug screening and discovery of novel biomarkers; combinedly, these advances exhibit the potential of SCA to study of human aging and disease. Primarily, we review the role of SCA in understanding cellular mechanisms involved in aging and other major diseases including neurological, vascular, autoimmunity and cancer. Secondly, we also include review of SCA role in studying cell adhesion mechanisms which are involved in tissue development and maintenance and disease progression. Finally, SCA potential to empower precision medicine and its overall challenges along with future directions are discussed.

    Citation: Uday Chintapula, Samir M Iqbal, Young-Tae Kim. A compendium of single cell analysis in aging and disease[J]. AIMS Molecular Science, 2020, 7(1): 49-69. doi: 10.3934/molsci.2020004

    Related Papers:

    [1] Marek Bodnar, Monika Joanna Piotrowska, Urszula Foryś, Ewa Nizińska . Model of tumour angiogenesis -- analysis of stability with respect to delays. Mathematical Biosciences and Engineering, 2013, 10(1): 19-35. doi: 10.3934/mbe.2013.10.19
    [2] Shishi Wang, Yuting Ding, Hongfan Lu, Silin Gong . Stability and bifurcation analysis of SIQR for the COVID-19 epidemic model with time delay. Mathematical Biosciences and Engineering, 2021, 18(5): 5505-5524. doi: 10.3934/mbe.2021278
    [3] Zhichao Jiang, Xiaohua Bi, Tongqian Zhang, B.G. Sampath Aruna Pradeep . Global Hopf bifurcation of a delayed phytoplankton-zooplankton system considering toxin producing effect and delay dependent coefficient. Mathematical Biosciences and Engineering, 2019, 16(5): 3807-3829. doi: 10.3934/mbe.2019188
    [4] Xin-You Meng, Yu-Qian Wu . Bifurcation analysis in a singular Beddington-DeAngelis predator-prey model with two delays and nonlinear predator harvesting. Mathematical Biosciences and Engineering, 2019, 16(4): 2668-2696. doi: 10.3934/mbe.2019133
    [5] Kalyan Manna, Malay Banerjee . Stability of Hopf-bifurcating limit cycles in a diffusion-driven prey-predator system with Allee effect and time delay. Mathematical Biosciences and Engineering, 2019, 16(4): 2411-2446. doi: 10.3934/mbe.2019121
    [6] Leo Turner, Andrew Burbanks, Marianna Cerasuolo . PCa dynamics with neuroendocrine differentiation and distributed delay. Mathematical Biosciences and Engineering, 2021, 18(6): 8577-8602. doi: 10.3934/mbe.2021425
    [7] Yong Yao . Dynamics of a delay turbidostat system with contois growth rate. Mathematical Biosciences and Engineering, 2019, 16(1): 56-77. doi: 10.3934/mbe.2019003
    [8] Marek Bodnar, Monika Joanna Piotrowska, Urszula Foryś . Gompertz model with delays and treatment: Mathematical analysis. Mathematical Biosciences and Engineering, 2013, 10(3): 551-563. doi: 10.3934/mbe.2013.10.551
    [9] Hongying Shu, Wanxiao Xu, Zenghui Hao . Global dynamics of an immunosuppressive infection model with stage structure. Mathematical Biosciences and Engineering, 2020, 17(3): 2082-2102. doi: 10.3934/mbe.2020111
    [10] Hongfan Lu, Yuting Ding, Silin Gong, Shishi Wang . Mathematical modeling and dynamic analysis of SIQR model with delay for pandemic COVID-19. Mathematical Biosciences and Engineering, 2021, 18(4): 3197-3214. doi: 10.3934/mbe.2021159
  • Cell is the fundamental structural and functional unit of complex multicellular organisms. Conventional methods which involve average analysis of cells in bulk populations can undermine physiologically significant cell populations, whereas analysis of cells at a single cell level may reveal unique biomarkers and other mechanisms that govern the genotype and phenotype in various physiological processes in presumed homogenous cell populations. Cellular abnormalities such as irregularities in cellular mechanisms have been linked to human aging and other major diseases including neurodegenerative, vascular, autoimmune, and cancer. Aging is a functional decline associated with various diseases in an organism, majorly arising from cellular abnormalities. Single cell analysis (SCA) which involves isolation and study of single cell proteomics, genomics, transcriptomics and metabolomics which enables research of cellular abnormalities with a molecular resolution, is gaining recognition in the research of human aging and disease. The advances in SCA are producing breakthrough information about cellular heterogeneity, disease progression, cellular microenvironment and its interactions, early diagnostics, improving precision medicine through high throughput drug screening and discovery of novel biomarkers; combinedly, these advances exhibit the potential of SCA to study of human aging and disease. Primarily, we review the role of SCA in understanding cellular mechanisms involved in aging and other major diseases including neurological, vascular, autoimmunity and cancer. Secondly, we also include review of SCA role in studying cell adhesion mechanisms which are involved in tissue development and maintenance and disease progression. Finally, SCA potential to empower precision medicine and its overall challenges along with future directions are discussed.


    1. Introduction

    In this paper we focus on the process of angiogenesis, which means formation of new vessels from pre-existing ones. It is a normal and vital process in growth and development of animal organisms, but it is also essential in the transition of avascular forms of solid tumours into metastatic ones. Small tumours (less than 1-2 mm3 of volume) receive nutrients from the outside by simple diffusion. Then necrotic core starts to grow, which is associated with the secretion of angiogenic factors by cancer cells. The supply of nutrients allows cancer to grow further, and moreover vessels form the path for spreading cancer cells in the organism.

    Mathematical modelling of this process is inextricably linked with the idea of anti-angiogenic treatment first considered by Folkman in 1971 (c.f.[15]). However, as anti-angiogenic agents were not known that time, it took more than 20 years for the specific models of angiogenesis and anti-angiogenic treatment appear (c.f.[17] were one of the best known models of it has been proposed).

    Various approaches were used to describe the angiogenesis process in mathematical language. The simplest approach is based on ordinary differential equations describing the dynamics of tumour and vasculature, like in the approach of Hahnfeldt et al.[17]. This idea was extended by many authors, including d'Onofrio and Gandolfi[14], Agur et al.[2], Bodnar and Foryś[8], Poleszczuk et al.[21], Piotrowska and Foryś[20,16]. However, in many cases spatio-temporal dynamics of vessels and tumour structure is important. To reflect such a structure one can use the approach of partial differential equations. First models of that type was based on reaction-diffusion equations with the process of chemotaxis taken into account; c.f.[12]. Many papers focusing on chemotaxis modelling was published by M. Chaplain and coauthors (c.f.[12], [19] where also haptotaxis process was considered, [3] with the influence of external forces). Yet another approach is based on cellular automata. Models of that type was proposed by Rieger and coauthors (c.f.[6,23]), while Alarcón et al.[1] considered hybrid cellular automaton in the context of multiscale modelling. Very nice review of various types of spatio-temporal models of vasculogenesis and angiogenesis processes could be find in[22], where a list of many other references on that topic is available.

    In this paper we consider the model of tumour angiogenesis proposed in[7] and studied in[9] in the context of discrete delays. However, discrete delays could be only an approximation of delays present in real life, and therefore, following[10] we decided to incorporate distributed delays and compare the results with those for the discrete case. We mainly focus on the Erlang distributions, however some results for general distributions are also obtained. Partial results for the distributed delay in the vessel formation process was presented in[5]. Here, we incorporate distributed delays both in the vessel formation and tumour growth processes. Thus we consider the following system of the first order differential equations with distributed delays

    ˙N(t)=αN(t)(1N(t)1+f1(h1(Et))),˙P(t)=f2(E(t))N(t)δP(t),˙E(t)=(f3(h2(Pt))dsα(1N(t)1+f1(h1(Et)))) E(t), (1.1)

    where N(t), P(t), E(t), α and δ describe the tumour size, the amount of regulating proteins, the effective vessel density, the tumour proliferation rate and the degradation of proteins, respectively. Both parameters could also include the influence of treatment.

    The functions hi:C((,0],R), i=1, 2, are defined as follows

    hi(ϕ)=0ki(s)ϕ(s)ds,

    and we assume ki(s):[0,)[0,) are probability densities with finite expectations, that is

    0ki(s)ds=1and0<0ski(s)ds<,i=1,2.

    For any ϕC(R,R), the function ϕt is defined as ϕt(s)=ϕ(t+s) for s(,0].

    Moreover, we assume that the functions fi are locally Lipschitz and there exist positive constants A2, A3, B1, B3 and m3 such that

    (A1) f1 is increasing, f1(0)=0 and limE+f1(E)=B1>0,

    (A2) f2 is decreasing and convex, f2(0)=A2>0 and limE+f2(E)=0,

    (A3)f3 is increasing, f3(0)=A3<0, f3(m3)=0 and limP+f3(P)=B3.

    For detailed derivation of the model described by Eqs. (1.1) we refer to[7,9].

    To close the problem we need to define initial data. Let C=C((,0],R3) be the space of continuous functions defined on the interval (,0] with values in R3, and as C+ we define the subspace of C that consist of the functions with non-negative values. Because the distributions of delays have infinite supports, we need to control the behaviour of initial functions at infinity (see[18]). To this end, let define a Banach space Φ in the following way

    Φ={ϕC:limsϕ(s)es=0andsups(,0]|ϕ(s)es|<},ϕΦ=sups(,0]|ϕ(s)es|,

    and we consider initial functions from the set Φ+=ΦC+.


    2. Analysis of the model

    In this section we consider basic properties of system (1.1) for general distributions ki(s) and study stability in the case of Erlang distributions. For all results presented here we assume the functions fi, i=1,2,3, fulfil conditions (A1)-(A3).

    Theorem 2.1.  For any arbitrary initial function ϕ=(ϕN,ϕP,ϕE)Φ+ there exists a unique solution of system (1.1) in Φ+ defined on t[0,+). Moreover, for all t0 any solution satisfies the following inequalities

    NminN(t)Nmax,0P(t)max{A2δNmax,ϕ2(0)},0E(t)ϕ3(0)exp((B3+α(Nmax1))t), (2.1)

    where

    Nmin=min{1,ϕN(0)},Nmax=max{ϕN(0),1+B1}.

    Proof. It is easy to see that the right-hand side of system (1.1) is locally Lipschitz, which yields local existence of the solution of (1.1). Non-negativity follows from the form of this right-hand side. Inequalities (2.1) could be obtained in the same way as in[9]. Then the global existence of the solutions can be proved by the use of Theorem 2.7 from [18,Chapter 2].

    Now, we turn to steady states. It is obvious that there are at least two steady states

    A =(0,0,0)andB=(1,A2δ,0),

    compare [9]. Moreover, there can exist positive steady states Di=(¯Ni,m3,¯Ei), with ¯Ni=1+f1(¯Ei), and ¯Ei are zeros of the function

    g(x)=f2(x)(1+f1(x))δm3. (2.2)

    Stability of the steady states A and B does not depend on time delays, as in the discrete case; c.f.[9]. We recall the results without the proof.

    Proposition 2.2.   The trivial steady state A of system (1.1) exists and is unstable independently of the model parameters. The semi-trivial steady state B of system (1.1) is locally asymptotically stable for A2<δm3 and unstable for A2>δm3.


    2.1. Stability of positive steady states

    In this section, we focus on examining the stability of the positive steady states Di in the case of distributed delays. First, we give some general results regarding stability and later we consider Erlang probability distribution, which is a special type of Gamma distribution with the shape parameter being a natural number.

    In the general case let us define

    Ki(λ)=0ki(s)eλsds. (2.3)

    Then, the stability matrix of system (1.1) for the steady state Di reads

    M(ˉN,ˉP,ˉE)=(αλ0αd1K1(λ)f2(¯Ei)δλ¯Ni d2αb¯Eid3¯EiK2(λ)αbd1¯EiK1(λ)λ),

    where

    b=11+f1(ˉEi),d1=f1(ˉEi)>0,d2=f2(ˉEi)>0,d3=f3(m3)>0.

    Hence, the characteristic quasi-polynomial has the form

    W(λ)=λ3+C1λ2+C2λ+(λ2+δλ)C3K1(λ)++(λ+α)C4K2(λ)C3C5K1(λ)K2(λ), (2.4)

    with

    C1=α+δ,C2=αδ,C3=αβd1,C4=βd2d3b2,C5=δd3m3,β=b¯Ei.

    Conditions (A1)-(A3) guarantee positivity of b, β and di, i=1, 2, 3. Consequently, Ci>0 for i=1,,5.

    Theorem 2.3.  If g(¯Ei)>0, where g is given by (2.2), then the positive steady state Di=(¯Ni,m3,¯Ei) is unstable.

    Proof. We show that the characteristic function (2.4) has at least one positive real root. In the proof of Theorem 3.4 in [9] it is shown that the sign of W(0)=αC4C3C5 is reverse to the sign of g(¯Ei). Therefore, the assumption g(¯Ei)>0 implies that W(0)<0. Further, it is easy to see that W(λ)+ as λ+. Then there exists at least one real positive eigenvalue, and this implies that Di is unstable.

    Now, we focus on the cases when only one of the considered processes is delayed and the other is instantaneous. First, we consider k2(s)=δD(s), where δD means Dirac-delta distribution, that is only the first delay is present in the system.

    In the theorem presented below we shall use the following auxiliary polynomials and positive zeros of these polynomials. Let us define

    w1(ω)=ω3C3ω2+(C2+C4δC3)ωC3C5, (2.5)
    w3(ω)=(C1+C3)ω2δC3ω+αC4C3C5, (2.6)

    and

    w4(ω)=(C1C3)ω2+δC3ω+αC4+C3C5. (2.7)

    To obtain positive zeros of w1 one needs to assume C2+C4δC3>0. Moreover, the value at positive extremum, that is at Pmax=2C3+4C23+12(C2+C4δC3)6, must be positive. Hence, it is necessary that w1(Pmax)>0. In such a case there exist two positive zeros P1<P2 of w1. Next, we easily see that if g(ˉEi)<0, that is αC4C3C5>0, then w3 has exactly one positive zero P3=δC3+δ2C234(C1+C3)(αC4C3C5)2(C1+C3). Similarly, if C1>C3, then w4 has exactly one positive zero

    P4=δC3+δ2C23+4(C1C3)(αC4+C3C2)2(C1C3).

    In the following, we require P1<P3 and P4<P2.

    Theorem 2.4.   Assume that g(¯Ei)<0 and Di=(¯Ni,m3,¯Ei) is a positive steady state of system (1.1). Assume also that the delay distribution k2 is concentrated at zero, that is k2(s)=δD(s). If

    (ⅰ)βd1<1 and

    2α2bd2¯Ei<d3<min{b2d2¯Ei(δ2α2(β2d121)), δ2β2d12m3(1β2d12)},

    or

    (ⅱ) C1>C3, w1(Pmax)>0 and w1(Pi)>0 for i=3, 4, where w1 is defined by (2.5) and P3, P4 are positive zeros of (2.6) and (2.7), respectively,

    then Di is locally asymptotically stable for any distribution k1.

    Proof. The steady state Di is stable in the case without delay for g(ˉEi)<0. Hence, we need to show that the characteristic function has no purely imaginary zeros. Therefore, we investigate the behaviour of W(iω).

    Let

    K1(iω)=η1iζ1,η1=0k1(s)cos(ωs)ds,  ζ1=0k1(s)sin(ωs)ds.

    Thus

    W(iω)=iω3C1ω2+i(C2+C4)ω+((ω2+iδω)C3C3C5)(η1iζ1)+αC4,

    and we have

    Re(W(iω))=C1ω2+αC4C3(ω2+C5)η1+δC3ωζ1,Im(W(iω))=ω3+(C2+C4)ω+δC3ωη1+C3(ω2+C5)ζ1. (2.8)

    Assume that there exists ω>0 such that W(iω)=0, then

    (C1ω2+αC4)2+(ω3+(C2+C4)ω)2=(C3(ω2+C5)η1+δC3ωζ1)2+(δC3ωη1+C3(ω2+C5)ζ1)2. (2.9)

    For Eq. (2.9) we have

    L.H.S=ω6+(C212(C2+C4))ω4+((C2+C4)22αC1C4)ω2+α2C24,R.H.S=C23(ω4+(δ2+2C5)ω2+C25)(ζ21+η21).

    Schwarz inequality yields

    (0cos(ωs)k1(s)ds)2=(0cos(ωs)d(s0k1(u)du))20cos2(ωs)d(s0k1(u)du)0d(s0k1(u)du)=0cos2(ωs)k1(s)ds,(0sin(ωs)k1(s)ds)20sin2(ωs)k1(s)ds.

    Consequently, ζ21+η211. Then, ω satisfying W(iω)=0 should fulfil

    0=L.R.S.R.H.S.
    ω6+(C212˜C2,4)ω4+((˜C2,4)22αC1C4)ω2++α2C24C23(ω4+(δ2+2C5)ω2+C25),

    where ˜C2,4=C2+C4. Let us denote y=ω2 and define the auxiliary function

    F(y)=y3+(C212˜C2,4C23)y2+((˜C2,4)22αC1C4C23(δ22C5))y++α2C24C23C25,

    Existence of purely imaginary eigenvalue requires F(y)0 for some positive y. However, all coefficients of this polynomial are positive under the assumptions, and then purely imaginary eigenvalue iy does not exist.

    Clearly, the free term is positive due to g(ˉEi)<0. Moreover, inequalities (i) are equivalent to

    βd1<1,α2<βd2d32b2and 
    δ>max{α2(β2d121)+2βd2d3b2,2β2d12d3m31β2d12}.

    Therefore,

    C212(C2+C4)C23=δ2α2(β2d121)2βd2d3b2>0,
    (C2+C4)22αC1C4δ2C232C23C5=(αδ+βd2d3b2)22α(δ+α)βd2d3b2δ2α2β2d122α2β2d12δd3m3=((1β2d12)α2δ2α2β2d12d3m3)δ+βd2d3b2(βd2d3b22α2)>0.

    Due to the continuous dependance of eigenvalues on the model parameters this completes the proof of the first part.

    For the proof of the second part, notice that (2.8) implies

    Re(W(iω))(C1+C3)ω2δC3ω+αC4C3C5,Re(W(iω))(C1C3)ω2+δC3ω+αC4+C3C5,Im(W(iω))ω3C3ω2+(C2+C4δC3)ωC3C5.

    It is clear that,

    Re(W(iω))>0 for ω[0,P3),and Im(W(iω))>0 for ω(P1,P2),Re(W(iω))<0 for ω(P4,).

    Inequalities w1(Pi)>0 for i=3, 4, imply P1<P3 and P2>P4. Moreover, w3(0)<w4(0) and w3(ω)<w4(ω) for ω>0. Therefore P3<P4 and there is no ω0 such that W(iω)=0. This completes the proof of the theorem.

    Remark 1.  If the second condition of assumption (ⅰ) of Theorem 2.4 is satisfied, then

    δ2>3α2.

    If this inequality holds, we can choose sufficiently small d1 and later we can take a proper value of d3 such that the condition (i) of Theorem 2.4 holds.

    In the following, we shall consider Erlang distributed delays. The density of Erlang distribution is given by

    k(s)={am(sσ)m1(m1)!ea(sσ),sσ,0,otherwise, (2.10)

    where a, σ>0, and a is a scaling parameter. To the case σ=0 we refer as to the non-shifted Erlang distribution, while to the case σ>0 we refer as to the shifted one. The mean value of the non-shifted Erlang distribution is given by ma and the variance is equal to ma2. The average delay is equal to this mean, obviously, and the deviation measures the concentration of the delay about the average value. For the shifted Erlang distribution the mean value is σ+ma and the variance is the same as for the non-shifted one. On the other hand, taking the limit m+ and keeping m/a=τ constant we obtain system (1.1) with discrete delay τ. By direct calculation, it is found that 0k(s)eλsds=am(a+λ)meλσ.

    Now, let us consider the first distribution to be Erlang, k1(s)=k(s), while the other is still k2(s)=δD(s). In this case, if C5a(aδ), then the characteristic function (2.4) could be replaced by

    WI(λ)=(a+λ)m(λ3+C1λ2+(C2+C4)λ+αC4)++am(C3λ2+δC3λC3C5)eλσ. (2.11)

    As the case C5=a(aδ) is non-generic, in the following we assume C5a(aδ), and consider the simplest possible Erlang distribution with m=1 and σ=0.

    Theorem 2.5.  If m=1, σ=0 and g(¯Ei)<0, then the positive steady state Di is locally asymptotically stable.

    Proof. For this case the characteristic function WI simplifies to

    WI(λ)=(a+λ)(λ3+C1λ2+(C2+C4)λ+αC4)+a(C3λ2+δC3λC3C5).

    The Routh-Hurwitz Criterion for WI reads

    q1q2q3>q23+q21q4, (2.12)

    where

    q1=a+C1,q2=a(C1+C3)+η2,q3=a(η2+δC3)+αC4,q4=aη4, 

    and

    η2=C2+C4,η4=αC4C3C5,

    Notice that inequality (2.12) is equivalent to

    P(a)=a3a3+a2a2+a1a +a0>0,

    where

    a3=(C1+C3)(η2+δC3)η4,a2=αC4(C1+C3)+C2(η2+δC3)+C1(C1+C3)(η2+δC3)    +C4(η2+δC3)(η2+δC3)22C1η4,a1=C1(η22+αC3C4+δC3η2)αC4(η2+2δC3)+C21C3C5,a0=αC4(C1η2αC4).

    Due to the definitions of C1 and ηi we have:

    a0=αC4((δ+α)(C2+C4)αC4)=αC4((δ+α)C2+δC4)>0,a1=(α+δ)((C2+C4)2+αC3C4+δC3(C2+C4))αC4(C2+C4)+2αδC3C4+C21C3C5=α(η2C2+αC3C4+δC2C3)+δη2(η2+δC3)>0,a2=αC4C3+C2(η2+δC3)+(C1(α+δ)+C1C3)(η2+δC3)+C4(η2+δC3)+(η2+δC3)2αC1C4+2C3C5,=αC4C3+(δC1+(α+δ)C3)(η2+δC3)+αC1(C2+δC3)+δC2C3δC4C3δ2C23+2C3C5,=αC4C3+(δC1+α)C3(η2+δC3)+αC1(C2+δC3)+2C3C5>0,a3=(δ+α+C3)(C2+C4+δC3)αC4+C3C5=(δ+C3)(C2+C4+δC3)+α(C2+δC3)+C3C5>0.

    Hence, P(a)>0 for every positive a. This means that the condition of stability is always satisfied.

    Remark 2.  Although Theorem 2.4 gives condition guaranteeing stability of the positive steady state for any delay distribution, Theorem 2.5 says that the positive steady state, if it is stable for the case without delay, cannot lose stability when the tumour growth process is delayed according to the Erlang distribution.

    Now, we switch to the case when k1(s)=δD(s), while the second distribution is Erlang, that is k2(s)=k(s) described by Eq. (2.10). Note that if αC4C4a+C3C5, then λ is the eigenvalue defined by (2.4) if and only if λ is zero of

    WII(λ)=(a+λ)m(λ3+(C1+C3)λ2+(C2+δC3)λ)++am(C4λ+αC4C3C5)eλσ. (2.13)

    Again, because the case αC4=C4a+C3C5 is non-generic, we do not consider it here, and in the following we assume αC4C4a+C3C5. Thus, studying the stability of the positive steady states Di of system (1.1) is equivalent to study zeros of the polynomial WII defined by (2.13). Below, we again study the simplest case of Erlang distribution with m=1 and σ=0.

    Proposition 2.6.  If m=1, σ=0, g(¯Ei)<0 and Q1Q2Q3>Q23+Q21Q4, where

    Q1=C1+C3+a,Q2=C2+δC3+a(C1+C3),Q3=a(C2+C4+δC3),Q4=a(αC4C3C5),

    then the positive steady state Di is locally asymptotically stable.

    Proof. For m=1 and σ=0, the polynomial WII defined by (2.13) reads

    WII(λ)=λ4+(C1+C3+a)λ3+(C2+δC3+a(C1+C3))λ2++a(C2+C4+δC3)λ+a(αC4C3C5),

    and the assertion of the proposition comes directly from the Routh-Hurwitz Criterion.

    Now, we try to answer the question when the assumptions of Proposition 2.6 are satisfied. To simplify calculations and shorten notation, let us denote

    η1=C1+C3,η2=C2+δC3,η4=αC4C3C5.

    With this notation we have

    Q1=η1+a,Q2=η2+aη1,Q3=a(η2+C4),Q4=aη4,
    Qi>0  for  i=1,,4.

    Now, the Routh-Hurwitz condition is equivalent to

    a2(η1(η2+C4)η4)+a((η2+C4)(η21C4)2η1η4)++η1(η2(η2+C4)η1η4)>0. (2.14)

    Notice that the coefficient of a2 is positive. Clearly, using the definitions of η1, η4 and C1 we have

    η1(η2+C4)η4=η1η2+(α+δ+C3)C4αC4+C3C5=η1η2+(δ+C3)C4+C3C5>0.

    Now, we have only three possibilities:

    1. η2(η2+C4)<η1η4 -there exists exactly one critical value of a, below which the steady state is unstable and above which it is stable (average delay is 1/a in this case);

    2.(η2+C4)(η21C4)/2<η1η4<η2(η2+C4) and the discriminant of the quadratic polynomial is positive -there exist two critical values of a;

    3.η1η4<η2(η2+1) and either η1η4<(η2+C4)(η21C4)/2 or the discriminant of the quadratic polynomial is negative -the steady state is stable for all a.

    To obtain two changes of stability, we need to have

    ((η2+C4)(η21C4)2η1η4)2>4η1(η2(η2+C4)η1η4)(η1(η2+C4)η4), (2.15)

    together with

    (η21C4)(η2+C4)2<η1η4<η2(η2+C4).

    Inequality (2.15) is equivalent to

    (η2+C4)(η21C4)24η1η4(η21C4)4η21η2(η2+C4)+4η1η2η4+4η31η4>0,

    and collecting terms with η21C4 we obtain

    (η2+C4)(η21C4)24η1η4(η21C4)+4η1(η4(η2+η21)η1η2(η2+C4))>0. (2.16)

    Notice that the free and linear terms of (2.16) are positive under the assumption

    η4>η1η2(η2+C4)η2+η21andη21<C4.

    We have η21C4=(α+δ+αδ)2βd2d3/b2, and it is negative for sufficiently large d2d3 or sufficiently small b.

    Eventually, two stability switches are possible under the assumptions

    η1η2(η2+C4)η2+η21<η4<η2(η2+C4)η1andη21<C4.

    Proposition 2.7.  If g(ˉEi)0 and

    (ⅰ)Di is unstable for σ=0, then it is unstable for all σ>0;

    (ⅱ)Di is stable for σ=0, then there exists σ0>0, such that Di is stable for σ<σ0, and Di is unstable for σ>σ0. Furthermore, if fiC2,i =1,2,3, then Hopf bifurcation occurs at σ0.

    Proof.  For the characteristic function WII given by (2.13), we define the auxiliary function

    F(y)=y(a2+y)m(y2+((C1+C3)22(C3δ+C2))y+(C3δ+C2)2)a2mC24ya2m(C4αC3C5)2,

    where y=ω2. Notice, that

    (C1+C3)22(C3δ+C2)=α2(1+βd1)2+δ2>0.

    Clearly, F has at least one positive zero, since the coefficient of y with the highest power is positive, while the free term is negative. We show that this is the unique simple positive root. Note, that all coefficients of F are positive with the exception of the free term which is negative and the coefficient of y, which sign is not determined. However, in both cases, there exists exactly one change of sign in the coefficients of the polynomial F, and the Descartes' Rule of Signs implies that F has a unique and simple positive root. This, together with Theorem 1 from [13], completes the proof.

    Eventually, we consider both distributions to be Erlang with the same parameters.

    Proposition 2.8.   If m=1, σ=0, g(¯Ei)<0, q11q22q33>q233+q211q44 and

    (q11q44q55)(q11q22q33q233q211q44)>q55(q11q22q33)2+q11q255,

    where

    q11=C1+2a ,q22=C2+2a C1+a2+aC3,q33=2a C2+a2C1+a2C3+aC3δ+aC4,q44=a2C2+a2C3δ+a2C4+aC4α,q55=a2C4αa2C3C5,

    then the positive steady state Di is locally stable.

    Proof. For m=1 and σ=0, the characteristic function (2.4) reads

    W(λ)=1(a+λ)2((λ3+C1λ2+C2λ)(a+λ)2+a(λ2+δλ)C3(a+λ)++a(λ+α)C4(a+λ)a2C3C5).

    Hence, we need to study roots of the polynomial

    λ5+(C1+2a )λ4+(C2+2a C1+a2+aC3)λ3+(2a C2+a2C1+a2C3+aC3δ+aC4)λ2++(a2C2+a2C3δ+a2C4+aC4α)λ+a2C4αa2C3C5=0.

    A direct application of the Routh-Hurwitz Criterion completes the proof.


    3. Numerical simulations

    For the numerical simulations we choose functions fi and parameters values proposed in[9], that is

    f1(E)=b1Enc1+En,f2(E)=a2c2c2+E,f3(P)=b3(P2m23)m23b3a3+P2,

    and

    a2=0.4,  a3=1,  b1=2.3,  b3=1,  c1=1.5,  c2=1,  α=1,  δ=0.34. (3.1)

    For these values of parameters there exist three positive steady states:

    D1(1.04,1.05,0.17),D2(1.37,1.05,0.54),D3(2.67,1.05,1.99).

    Now, we can influence the model dynamics changing the value of δ. This parameter could reflect an application of some treatment that blocks VEGF activation, which can be modelled by the increase of clearance rate. Then the steady state D1 exists for 0.331<δ<0.381, D3 for δ<0.368 and D2 for 0.331<δ<0.368. The steady state D2 is unstable, while D1 and D3 are stable for the case without time delay.

    In Table 1 we presented critical values of delay at which the steady states D1 and D3 lose their stability, for some values of parameter δ, in the case of discrete delay, as well as the critical average delay at which the steady states D1 and D3 lose their stability for the case of the Erlang delay distribution, both in the vessel formation process, while the process of tumour growth is instantaneous. The average delay is calculated as m/a. These results are also illustrated in Fig. 1. Numerical simulations suggest that if δ converges to the limits of the interval of the existence of the steady state D1, (average) critical value of delay tends to +. Similar behaviour is observed for critical value of time delay for the steady state D3, however for this state the interval of existence is bounded only from the right-hand side. It can be also noticed that for m=1, the positive steady states do not change their stability, and this result is similar to those obtained when the tumour growth is delayed according to the Erlang distribution with m=1. However, in the latter case the stability does not depend on other model parameters, while in the first case it depends on the model parameters. Numerical simulations suggest that for δ close to 0.346 the critical value of delay for the steady state D1 is the smallest one while it is larger for other δ. The regions below the curves in Fig. 1 are stability regions. For the state D1 stability regions for Erlang distributions is larger than in the discrete case, and decreases with increasing m. On the other hand, for the steady state D3, the critical value of delay seems to be an increasing function of δ. For some values of δ the region of stability in the case of m=2 is more than twice as large as in the discrete case. However, numerical simulations suggest, that for δ close to 0.3, the stability region for the Erlang distribution with m=5 is smaller than for the discrete case, and this is somehow unexpected result.

    Table 1. Critical values of τ at which the positive steady state loses stability.
    steady state D1 steady state D3
    δ 0.332 0.346 0.36 0.368 0.378 0.3 0.332 0.346 0.36 0.368
    discrete 66.7 33.4 29.3 43.6 182 4.49 5.89 7.53 13.0 94.0
    m=1 steady state does not lose stability
    m=2 176 54.7 69.1 106.1 460 5.58 9.36 14.4 32.2 284
    m=5 89.9 29.6 37.4 56.6 234 4.03 5.97 8.34 16.6 135
     | Show Table
    DownLoad: CSV
    Figure 1. Critical average delay, that is m/acr for various values of m in the dependance on δ in the case when only the process of tumour growth is delayed; left -graphs for the steady state D1, right -graphs for the steady state D3.

    In Fig. 2 we see exemplary solutions of system (1.1) for parameters given by (3.1) and τ=10. For m=1 the solution converges to the steady state very fast, while for m=5 it seems that oscillations are sustained.

    Figure 2. Solutions of system (1.1) for parameters given by (3.1) and τ=10, with time delay present only in the vessel formation term.

    For comparison, we present solutions of system (1.1) with Erlang distributed delay with parameters m=1 and σ=0 or discrete delay present only in the tumour growth process. In this case Theorem 2.5 shows that the steady state is stable independently of the model parameters. This is seen in Fig. 3. Eventually, we present the case of both processes delayed with the same Erlang distribution in Fig. 4.

    Figure 3. Solutions of system (1.1) for parameters given by (3.1) and τ=10, with time delay present only in the tumour growth term. Here, for Erlang distribution, the steady state is stable, and solutions for m=1 and m=5 are almost identical.
    Figure 4. Solutions of system (1.1) for parameters given by (3.1) and τ=5, with time delay present in both terms.

    From our numerical analysis it is clear that the most robust is the model with Erlang distribution with m=1, while the most sensitive is the model with discrete delays. Moreover, in the case when the delay is present only in the tumour growth process, the influence of the magnitude of m is almost not visible. As we expect, for both delays being present, the behaviour of solutions is much more unpredictable. However, the result for m=1 seems to be optimistic. Clearly, Erlang distribution with m=1 is the most reasonable, and therefore this means that in reality oscillatory behaviour should be exception not rule.


    4. Conclusions and discussion

    In this paper a model of tumour angiogenesis with distributed delays was considered. We proved basic mathematical properties of the model showing that solutions are unique, non-negative and well defined on the whole positive half-line. We formulated conditions on the model parameters that guarantee lack of change of local stability of a steady state for any distribution of delays. On the other hand, we proved condition under which stability change can take place and Hopf bifurcation occurs. We gave more strict conditions in the case when delays are distributed according to Erlang distributions. Our results indicate that the model with distributed delays is more stable than with discrete ones. In particular, we observe stabilisation of the solution in a steady state value for some delay distributions while in the same time solutions of the model with discrete delays exhibit oscillations. In the case of Erlang distributions we observe that the behaviour of the solution for large shape parameter is closer to the behaviour of the solution to the model with discrete delays.

    The model considered in this paper is an extension of the model proposed earlier by Agur et. al.[2]. In this paper Agur et al. tried to simplified more complex computer model of angiogenesis process proposed in[4]. However, this model always exhibits oscillatory dynamics, which is not realistic. On the other hand, according to the data presented in[4], such type of the dynamics should be also present in the model, and therefore they included time delays into their model. Our idea was to combine the properties of the Hahnfeldt et al. model with the properties of the one presented in[2]. Here we decided to use distributed delays instead of discrete ones in order to make the model more realistic comparing to the previous discrete case[7]. Our results show that both type of the model dynamics could be observed for the model with delays distributed according to Erlang distributions, depending on the shape parameter, which is good from the point of view of potential applications. Although we have not validated our model with experimental data, it is done for a small modification of this model and the results should be published shortly; c.f.[11].



    Acknowledgments



    Graphical figures created using Biorender.

    Conflict of interest



    The authors declare no conflict of interest for the contributions in this manuscript.

    [1] Armbrecht L, Dittrich PS (2017) Recent Advances in the Analysis of Single Cells. Anal Chem 89: 2-21. doi: 10.1021/acs.analchem.6b04255
    [2] Al Amir Dache Z, Otandault A, Tanos R, et al. (2020) Blood contains circulating cell-free respiratory competent mitochondria. FASEB J 34: 3616-3630. doi: 10.1096/fj.201901917RR
    [3] Tritschler S, Theis FJ, Lickert H, et al. (2017) Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas. Mol Metab 6: 974-990. doi: 10.1016/j.molmet.2017.06.021
    [4] Ryan FP (2016) Viral symbiosis and the holobiontic nature of the human genome. APMIS 124: 11-19. doi: 10.1111/apm.12488
    [5] Dimijian GG (2000) Evolving together: the biology of symbiosis, part 2. Proc (Bayl Univ Med Cent) 13: 381-390. doi: 10.1080/08998280.2000.11927712
    [6] Hofmeyr JHS (2008) The harmony of the cell: cellular processes. Essays Biochem 45: 57-66. doi: 10.1042/bse0450057
    [7] Lane N, Martin W (2010) The energetics of genome complexity. Nature 467: 929-934. doi: 10.1038/nature09486
    [8] Wallace DC (2007) Why Do We Still Have a Maternally Inherited Mitochondrial DNA? Insights from Evolutionary Medicine. Annu Rev Biochem 76: 781-821. doi: 10.1146/annurev.biochem.76.081205.150955
    [9] Mojtahedi M, Skupin A, Zhou J, et al. (2016) Cell Fate Decision as High-Dimensional Critical State Transition. PLoS Biol 14: 1-29. doi: 10.1371/journal.pbio.2000640
    [10] From M, Hematopoietic P (2015) Brief Report: Single-Cell Analysis Reveals Cell Division-Independent Emergence of Stem Cells. Stem Cells 33: 3152-3157. doi: 10.1002/stem.2106
    [11] Kolodziejczyk AA, Kim JK, Svensson V, et al. (2015) The Technology and Biology of Single-Cell RNA Sequencing. Mol Cell 58: 610-620. doi: 10.1016/j.molcel.2015.04.005
    [12] Ziegenhain C, Vieth B, Parekh S, et al. (2017) Comparative Analysis of Single-Cell RNA Sequencing Methods. Mol Cell 65: 631-643.e4. doi: 10.1016/j.molcel.2017.01.023
    [13] Rosenberg AB, Roco CM, Muscat RA, et al. (2018) Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding. Science 360: 176-182. doi: 10.1126/science.aam8999
    [14] Lee BWL, Ghode P, Ong DST (2019) Redox regulation of cell state and fate. Redox Biol 25: 101056. doi: 10.1016/j.redox.2018.11.014
    [15] Trapnell C (2015) Defining cell types and states with single-cell genomics. Genome Res 25: 1491-1498. doi: 10.1101/gr.190595.115
    [16] MacLean AL, Hong T, Nie Q (2018) Exploring intermediate cell states through the lens of single cells. Curr Opin Syst Biol 9: 32-41. doi: 10.1016/j.coisb.2018.02.009
    [17] Hu P, Zhang W, Xin H, et al. (2016) Single Cell Isolation and Analysis. Front Cell Dev Biol 4: 1-12.
    [18] Armbrecht L, Dittrich PS (2017) Recent Advances in the Analysis of Single Cells. Anal Chem 89: 2-21. doi: 10.1021/acs.analchem.6b04255
    [19] Bengtsson M, Ståhlberg A, Rorsman P, et al. (2005) Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels. Genome Res 15: 1388-1392. doi: 10.1101/gr.3820805
    [20] Wang J, Min Z, Jin M, et al. (2015) Protocol for Single Cell Isolation by Flow Cytometry BT- Single Cell Sequencing and Systems Immunology. Single Cell Sequencing and Systems Immunology, Translational Bioinformatics Dordrecht: Springer, 155-163. doi: 10.1007/978-94-017-9753-5_11
    [21] Espina V, Wulfkuhle JD, Calvert VS, et al. (2006) Laser-capture microdissection. Nat Protoc 1: 586-603. doi: 10.1038/nprot.2006.85
    [22] Reece A, Xia B, Jiang Z, et al. (2016) Microfluidic techniques for high throughput single cell analysis. Curr Opin Biotechnol 40: 90-96. doi: 10.1016/j.copbio.2016.02.015
    [23] Torres AJ, Hill AS, Love JC (2014) Nanowell-based immunoassays for measuring single-cell secretion: characterization of transport and surface binding. Anal Chem 86: 11562-11569. doi: 10.1021/ac4030297
    [24] Islam M, Sajid A, Mahmood MAI, et al. (2015) Nanotextured polymer substrates show enhanced cancer cell isolation and cell culture. Nanotechnology 26: 225101. doi: 10.1088/0957-4484/26/22/225101
    [25] Fang T, Shang W, Liu C, et al. (2019) Nondestructive Identification and Accurate Isolation of Single Cells through a Chip with Raman Optical Tweezers. Anal Chem 91: 9932-9939. doi: 10.1021/acs.analchem.9b01604
    [26] Muraro MJ, Dharmadhikari G, Grün D, et al. (2016) A Single-Cell Transcriptome Atlas of the Human Pancreas. Cell Syst 3: 385-394.e3. doi: 10.1016/j.cels.2016.09.002
    [27] Ji Y, Qi D, Li L, et al. (2019) Multiplexed profiling of single-cell extracellular vesicles secretion. Proc Natl Acad Sci 116: 5979-5984. doi: 10.1073/pnas.1814348116
    [28] Yeo T, Tan SJ, Lim CL, et al. (2016) Microfluidic enrichment for the single cell analysis of circulating tumor cells. Sci Rep 6: 22076. doi: 10.1038/srep22076
    [29] Yuan J, Sheng J, Sims PA (2018) SCOPE-Seq: a scalable technology for linking live cell imaging and single-cell RNA sequencing. Genome Biol 19: 227. doi: 10.1186/s13059-018-1607-x
    [30] Ettinger A, Wittmann T (2014) Fluorescence live cell imaging. Methods Cell Biol 123: 77-94. doi: 10.1016/B978-0-12-420138-5.00005-7
    [31] Ayan B, Ozcelik A, Bachman H, et al. (2016) Acoustofluidic coating of particles and cells. Lab Chip 16: 4366-4372. doi: 10.1039/C6LC00951D
    [32] Johnson BN, Mutharasan R (2016) Acoustofluidic particle trapping, manipulation, and release using dynamic-mode cantilever sensors. Analyst Dec 142: 123-131. doi: 10.1039/C6AN01743F
    [33] Mao Z, Li P, Wu M, et al. (2017) Enriching Nanoparticles via Acoustofluidics. ACS Nano 11: 603-612. doi: 10.1021/acsnano.6b06784
    [34] Acero Sanchez JL, Joda H, Henry OYF, et al. (2017) Electrochemical Genetic Profiling of Single Cancer Cells. Anal Chem 89: 3378-3385. doi: 10.1021/acs.analchem.6b03973
    [35] Long D, Shang Y, Qiu Y, et al. (2018) A single-cell analysis platform for electrochemiluminescent detection of platelets adhesion to endothelial cells based on Au@DL-ZnCQDs nanoprobes. Biosens Bioelectron 102: 553-559. doi: 10.1016/j.bios.2017.11.058
    [36] Zhang J, Zhou J, Pan R, et al. (2018) New Frontiers and Challenges for Single-Cell Electrochemical Analysis. ACS Sens 3: 242-250. doi: 10.1021/acssensors.7b00711
    [37] Yang W, Tu Z, Wang H, et al. (2018) The mechanism of reduced IgG/IgE-binding of beta-lactoglobulin by pulsed electric field pretreatment combined with glycation revealed by ECD/FTICR-MS. Food Funct 9: 417-425. doi: 10.1039/C7FO01082F
    [38] Umar A, Jaremko M, Burgers PC, et al. (2008) High-throughput proteomics of breast carcinoma cells: a focus on FTICR-MS. Expert Rev Proteomics 5: 445-455. doi: 10.1586/14789450.5.3.445
    [39] Tosevski V, Ulashchik E, Trovato A, et al. (2017) CyTOF Mass Cytometry for Click Proliferation Assays. Curr Protoc Cytom 81: 7.50.1-7.50.14.
    [40] Fletcher JS, Rabbani S, Henderson A, et al. (2008) A new dynamic in mass spectral imaging of single biological cells. Anal Chem 80: 9058-9064. doi: 10.1021/ac8015278
    [41] Shen Y, Tolic N, Masselon C, et al. (2004) Ultrasensitive proteomics using high-efficiency on-line micro-SPE-nanoLC-nanoESI MS and MS/MS. Anal Chem 76: 144-154. doi: 10.1021/ac030096q
    [42] VanInsberghe M, Zahn H, White AK, et al. (2018) Highly multiplexed single-cell quantitative PCR. PLoS One 13: e0191601. doi: 10.1371/journal.pone.0191601
    [43] Chen J, Xu Y, Shi Y, et al. (2019) Functionalization of Atomic Force Microscope Cantilevers with Single-T Cells or Single-Particle for Immunological Single-Cell Force Spectroscopy. J Vis Exp e59609.
    [44] Lulevich V, Zink T, Chen HY, et al. (2006) Cell Mechanics Using Atomic Force Microscopy-Based Single-Cell Compression. Langmuir 22: 8151-8155. doi: 10.1021/la060561p
    [45] Balasubramanian S, Kagan D, Hu CMJ, et al. (2011) Micromachine-enabled capture and isolation of cancer cells in complex media. Angew Chem Int Ed Engl 50: 4161-4164. doi: 10.1002/anie.201100115
    [46] Esteban-Fernandez de Avila B, Martin A, Soto F, et al. (2015) Single Cell Real-Time miRNAs Sensing Based on Nanomotors. ACS Nano 9: 6756-6764. doi: 10.1021/acsnano.5b02807
    [47] Zhang Y, Jin L, Xu J, et al. (2017) Dynamic characterization of drug resistance and heterogeneity of the gastric cancer cell BGC823 using single-cell Raman spectroscopy. Analyst 143: 164-174. doi: 10.1039/C7AN01287J
    [48] Franco D, Trusso S, Fazio E, et al. (2017) Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines. Spectrochim Acta A Mol Biomol Spectrosc 187: 15-22. doi: 10.1016/j.saa.2017.06.020
    [49] Bayani J, Squire JA (2004) Fluorescence in situ Hybridization (FISH). Curr Protoc cell Biol Chapter 22: Unit 22.4.
    [50] Yurov YB, Vostrikov VM, Vorsanova SG, et al. (2001) Multicolor fluorescent in situ hybridization on post-mortem brain in schizophrenia as an approach for identification of low-level chromosomal aneuploidy in neuropsychiatric diseases. Brain Dev 23: 186-190. doi: 10.1016/S0387-7604(01)00363-1
    [51] Querido E, Dekakra-Bellili L, Chartrand P (2017) RNA fluorescence in situ hybridization for high-content screening. Methods 126: 149-155. doi: 10.1016/j.ymeth.2017.07.005
    [52] Ravindranathan A, Diolaiti ME, Cimini BA, et al. (2019) In Situ Visualization of Telomere Length, Telomere Elongation, and TERT Expression in Single Cells. Curr Protoc Cell Biol 85: e97. doi: 10.1002/cpcb.97
    [53] Habib N, Li Y, Heidenreich M, et al. (2016) Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons. Science 353: 925-928. doi: 10.1126/science.aad7038
    [54] Spaethling JM, Na YJ, Lee J, et al. (2017) Primary Cell Culture of Live Neurosurgically Resected Aged Adult Human Brain Cells and Single Cell Transcriptomics. Cell Rep 18: 791-803. doi: 10.1016/j.celrep.2016.12.066
    [55] Morita Y, Ema H, Nakauchi H (2010) Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 207: 1173-1182. doi: 10.1084/jem.20091318
    [56] Sarkar S, Motwani V, Sabhachandani P, et al. (2015) T Cell Dynamic Activation and Functional Analysis in Nanoliter Droplet Microarray. J Clin Cell Immunol 6: 334. doi: 10.4172/2155-9899.1000334
    [57] Ludwig LS, Lareau CA, Ulirsch JC, et al. (2019) Lineage Tracing in Humans Enabled by Mitochondrial Mutations and Single-Cell Genomics. Cell 176: 1325-1339.e22. doi: 10.1016/j.cell.2019.01.022
    [58] Mishra P, Martin DC, Androulakis IP, et al. (2019) Fluorescence Imaging of Actin Turnover Parses Early Stem Cell Lineage Divergence and Senescence. Sci Rep 9: 10377. doi: 10.1038/s41598-019-46682-y
    [59] Mansur N, Hasan MR, Kim Y, et al. (2017) Functionalization of nanotextured substrates for enhanced identification of metastatic breast cancer cells. Nanotechnology 28: 385101. doi: 10.1088/1361-6528/aa7f84
    [60] Nguyen AT, Sathe SR, Yim EKF (2016) From nano to micro: topographical scale and its impact on cell adhesion, morphology and contact guidance. J Phys Condens Matter 28: 183001. doi: 10.1088/0953-8984/28/18/183001
    [61] Palmer CP, Mycielska ME, Burcu H, et al. (2008) Single cell adhesion measuring apparatus (SCAMA): Application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression. Eur Biophys J 37: 359-368. doi: 10.1007/s00249-007-0219-2
    [62] Dong H, Sun H, Zheng J (2016) A microchip for integrated single-cell genotoxicity assay. Talanta 161: 804-811. doi: 10.1016/j.talanta.2016.09.040
    [63] Du Y, Li N, Yang H, et al. (2017) Mimicking Liver Sinusoidal Structures and Functions using a 3D-configured Microfluidic Chip. Lab Chip 17-20.
    [64] Kaminski TS, Scheler O, Garstecki P (2016) Droplet microfluidics for microbiology: techniques, applications and challenges. Lab Chip 16: 2168-2187. doi: 10.1039/C6LC00367B
    [65] Gawel DR, Serra-Musach J, Lilja S, et al. (2019) A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases. Genome Med 11: 47. doi: 10.1186/s13073-019-0657-3
    [66] Vaux DL, Haecker G, Strasser A (1994) An Evolutionary on Apoptosis Perspective Minireview. Cell 76: 777-779. doi: 10.1016/0092-8674(94)90350-6
    [67] Kowalczyk MS, Tirosh I, Heckl D, et al. (2015) Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res 25: 1860-1872. doi: 10.1101/gr.192237.115
    [68] Apple DM, Solano-Fonseca R, Kokovay E (2017) Neurogenesis in the aging brain. Biochem Pharmacol 141: 77-85. doi: 10.1016/j.bcp.2017.06.116
    [69] Dulken BW, Buckley MT, Navarro Negredo P, et al. (2019) Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature 571: 205-210. doi: 10.1038/s41586-019-1362-5
    [70] Ximerakis M, Lipnick SL, Simmons SK, et al. (2018) Single-cell transcriptomics of the aged mouse brain reveals convergent, divergent and unique aging signatures. bioRxiv 440032.
    [71] Zhang Y, Kim MS, Jia B, et al. (2017) Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature 548: 52-57. doi: 10.1038/nature23282
    [72] Kim Y, Karthikeyan K, Chirvi S, et al. (2009) Neuro-optical microfluidic platform to study injury and regeneration of single axons. Lab Chip 9: 2576-2581. doi: 10.1039/b903720a
    [73] Iourov IY, Vorsanova SG, Yurov YB (2012) Single Cell Genomics of the Brain: Focus on Neuronal Diversity and Neu- ropsychiatric Diseases. Curr Genomics 13: 477-488. doi: 10.2174/138920212802510439
    [74] Graff J, Kim D, Dobbin MM, et al. (2011) Epigenetic Regulation of Gene Expression in Physiological and Pathological Brain Processes. Physiol Rev 91: 603-649. doi: 10.1152/physrev.00012.2010
    [75] Faggioli F, Vijg J, Montagna C (2011) Chromosomal aneuploidy in the aging brain. Mech Ageing Dev 132: 429-436. doi: 10.1016/j.mad.2011.04.008
    [76] Yurov YB, Vorsanova SG, Iourov IY (2009) GIN'n'CIN hypothesis of brain aging: deciphering the role of somatic genetic instabilities and neural aneuploidy during ontogeny. Mol Cytogenet 2: 23. doi: 10.1186/1755-8166-2-23
    [77] Kim DW, Washington PW, Wang ZQ, et al. (2019) Single cell RNA-Seq analysis identifies molecular mechanisms controlling hypothalamic patterning and differentiation. bioRxiv 657148.
    [78] Song R, Sarnoski EA, Acar M (2018) The Systems Biology of Single-Cell Aging. iScience 7: 154-169. doi: 10.1016/j.isci.2018.08.023
    [79] Coffman JA, Rieger S, Rogers AN, et al. (2016) Comparative biology of tissue repair, regeneration and aging. npj Regen Med 1: 16003. doi: 10.1038/npjregenmed.2016.3
    [80] Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18: 83. doi: 10.1186/s13059-017-1215-1
    [81] Safian MF, Zinn N, Seidler J, et al. (2016) Microquantification of phospholipid classes by stable isotope dilution and nanoESI mass spectrometry. Anal Bioanal Chem 408: 7663-7667. doi: 10.1007/s00216-016-9859-3
    [82] Simmons AJ, Scurrah CR, McKinley ET, et al. (2016) Impaired coordination between signaling pathways is revealed in human colorectal cancer using single-cell mass cytometry of archival tissue blocks. Sci Signal 9: rs11. doi: 10.1126/scisignal.aah4413
    [83] Ginsberg SD, Che S, Counts SE, et al. (2006) Single cell gene expression profiling in Alzheimer's disease. NeuroRx 3: 302-318. doi: 10.1016/j.nurx.2006.05.007
    [84] Elstner M, Morris CM, Heim K, et al. (2009) Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol 66: 792-798. doi: 10.1002/ana.21780
    [85] Darmanis S, Sloan SA, Zhang Y, et al. (2015) A survey of human brain transcriptome diversity at the single cell level. Proc Natl Acad Sci 112: 7285-7290. doi: 10.1073/pnas.1507125112
    [86] Yamada A, Renault R, Chikina A, et al. (2016) Transient microfluidic compartmentalization using actionable microfilaments for biochemical assays, cell culture and organs-on-chip. Lab Chip 16: 4691-4701. doi: 10.1039/C6LC01143H
    [87] Srikakulapu P, Hu D, Yin C, et al. (2016) Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice. Arterioscler Thromb Vasc Biol 36: 1174-1185. doi: 10.1161/ATVBAHA.115.306983
    [88] Winkels H, Ehinger E, Vassallo M, et al. (2018) Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry. Circ Res 122: 1675-1688. doi: 10.1161/CIRCRESAHA.117.312513
    [89] Gladka MM, Molenaar B, de Ruiter H, et al. (2018) Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Cytoskeleton-Associated Protein 4 as a New Modulator of Fibroblasts Activation. Circulation 138: 166-180. doi: 10.1161/CIRCULATIONAHA.117.030742
    [90] Jia G, Preussner J, Chen X, et al. (2018) Single cell RNA-seq and ATAC-seq analysis of cardiac progenitor cell transition states and lineage settlement. Nat Commun 9: 4877. doi: 10.1038/s41467-018-07307-6
    [91] Ashton MP, Eugster A, Dietz S, et al. (2019) Association of Dendritic Cell Signatures With Autoimmune Inflammation Revealed by Single-Cell Profiling. Arthritis Rheumatol 71: 817-828. doi: 10.1002/art.40793
    [92] Wollny D, Zhao S, Everlien I, et al. (2016) Single-Cell Analysis Uncovers Clonal Acinar Cell Heterogeneity in the Adult Pancreas. Dev Cell 39: 289-301. doi: 10.1016/j.devcel.2016.10.002
    [93] Kallionpää H, Somani J, Tuomela S, et al. (2019) Early Detection of Peripheral Blood Cell Signature in Children Developing β-Cell Autoimmunity at a Young Age. Diabetes 68: 2024-2034. doi: 10.2337/db19-0287
    [94] Jin Z, Fan W, Jensen MA, et al. (2017) Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy. Lupus Sci Med 4: e000202. doi: 10.1136/lupus-2016-000202
    [95] O'Gorman WE, Kong DS, Balboni IM, et al. (2017) Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients. J Autoimmun S0896-8411: 30412-7.
    [96] Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517: 293-301. doi: 10.1038/nature14189
    [97] Bedard PL, Hansen AR, Ratain MJ, et al. (2013) Tumour heterogeneity in the clinic. Nature 501: 355-364. doi: 10.1038/nature12627
    [98] Chung W, Eum HH, Lee HO, et al. (2017) Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun 8: 15081. doi: 10.1038/ncomms15081
    [99] Xin Y, Kim J, Ni M, et al. (2016) Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. Proc Natl Acad Sci U S A 113: 3293-3298. doi: 10.1073/pnas.1602306113
    [100] Gong H, Do D, Ramakrishnan R (2018) Single-Cell mRNA-Seq Using the Fluidigm C1 System and Integrated Fluidics Circuits. Methods Mol Biol 1783: 193-207. doi: 10.1007/978-1-4939-7834-2_10
    [101] DeLaughter DM (2018) The Use of the Fluidigm C1 for RNA Expression Analyses of Single Cells. Curr Protoc Mol Biol 122: e55. doi: 10.1002/cpmb.55
    [102] Capper D (2012) Addressing Diffuse Glioma as a Systemic Brain Disease With Single-Cell Analysis. Arch Neurol 69: 523. doi: 10.1001/archneurol.2011.2910
    [103] Wang Y, Waters J, Leung ML, et al. (2014) Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512: 155-160. doi: 10.1038/nature13600
    [104] Gorgannezhad L, Umer M, Islam MN, et al. (2018) Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Lab Chip 18: 1174-1196. doi: 10.1039/C8LC00100F
    [105] Burinaru TA, Avram M, Avram A, et al. (2018) Detection of Circulating Tumor Cells Using Microfluidics. ACS Comb Sci 20: 107-126. doi: 10.1021/acscombsci.7b00146
    [106] Islam M, Asghar W, Kim Y (2014) Cell Elasticity-based Microfluidic Label-free Isolation of Metastatic Tumor Cells. J Adv Med Med Res 4: 2129-2140. doi: 10.9734/BJMMR/2014/7392
    [107] Chen W, Weng S, Zhang F, et al. (2013) Nanoroughened Surfaces for E ffi cient Capture of Circulating Tumor Cells without Using Capture Antibodies. ACS Nano 7: 566-575. doi: 10.1021/nn304719q
    [108] Islam M, Hasan MR, Sajid A, et al. (2016) Electrical Profiling and Aptamer Functionalized Nanotextured Surface in a Single Biochip for the Detection of Tumor Cells. Funct Nanostruct 13-21.
    [109] Shen Y, Nakajima M, Kojima S, et al. (2011) Single cell adhesion force measurement for cell viability identification using an AFM cantilever-based micro putter. Meas Sci Technol 22: 115802. doi: 10.1088/0957-0233/22/11/115802
    [110] Huang S, Ingber DE (1999) The structural and mechanical complexity of cell-growth control. Nat Cell Biol 1: E131-138. doi: 10.1038/13043
    [111] Lasky LA, Singer MS, Dowbenko D, et al. (1992) An endothelial ligand for L-Selectin is a novel mucin-like molecule. Cell 69: 927-938. doi: 10.1016/0092-8674(92)90612-G
    [112] Szekanecz Z, Koch AE (2000) Cell-cell interactions in synovitis. Endothelial cells and immune cell migration. Arthritis Res 2: 368-373. doi: 10.1186/ar114
    [113] Okegawa T, Pong RC, Li Y, et al. (2004) The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 51: 445-457. doi: 10.18388/abp.2004_3583
    [114] Hirohashi S, Kanai Y (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581. doi: 10.1111/j.1349-7006.2003.tb01485.x
    [115] Perinpanayagam H, Zaharias R, Stanford C, et al. (2001) Early cell adhesion events differ between osteoporotic and non-osteoporotic osteoblasts. J Orthop Res 19: 993-1000. doi: 10.1016/S0736-0266(01)00045-6
    [116] Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197. doi: 10.1038/ni1276
    [117] Simon SI, Green CE (2005) Molecular Mechanics and Dynamics of Leukocyte Recruitment During Inflammation. Annu Rev Biomed Eng 7: 151-185. doi: 10.1146/annurev.bioeng.7.060804.100423
    [118] Oh KS, Patel H, Gottschalk RA, et al. (2017) Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action. Immunity 47: 298-309.e5. doi: 10.1016/j.immuni.2017.07.012
    [119] Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interaction induces apoptosis. J Cell Biol 124: 619-626. doi: 10.1083/jcb.124.4.619
    [120] Simpson CD, Anyiwe K, Schimmer AD (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272: 177-185. doi: 10.1016/j.canlet.2008.05.029
    [121] Trott DW, Henson GD, Ho MHT, et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109: 99-107. doi: 10.1016/j.exger.2016.12.016
    [122] Valencia AMJ, Wu PH, Yogurtcu ON, et al. (2015) Collective cancer cell invasion induced by coordinated contractile stresses. Oncotarget 6: 43438-43451. doi: 10.18632/oncotarget.5874
    [123] Helenius J, Heisenberg CP, Gaub HE, et al. (2008) Single-cell force spectroscopy. J Cell Sci 121: 1785-1791. doi: 10.1242/jcs.030999
    [124] Mao S, Zhang Q, Li H, et al. (2018) Measurement of Cell–Matrix Adhesion at Single-Cell Resolution for Revealing the Functions of Biomaterials for Adherent Cell Culture. Anal Chem 90: 9637-9643. doi: 10.1021/acs.analchem.8b02653
    [125] Kwon KW, Choi SS, Lee SH, et al. (2007) Label-free, microfluidic separation and enrichment of human breast cancer cells by adhesion difference. Lab Chip 7: 1461-1468. doi: 10.1039/b710054j
    [126] de Wit J, Ghosh A (2015) Specification of synaptic connectivity by cell surface interactions. Nat Rev Neurosci 17: 4. doi: 10.1038/nrn.2015.3
    [127] Speicher MR (2013) Single-cell analysis: toward the clinic. Genome Med 5: 74. doi: 10.1186/gm478
    [128] Xie Y, Nama N, Li P, et al. (2016) Probing Cell Deformability via Acoustically Actuated Bubbles. Small 12: 902-910. doi: 10.1002/smll.201502220
    [129] Shaffer SM, Dunagin MC, Torborg SR, et al. (2017) Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546: 431-435. doi: 10.1038/nature22794
    [130] Yuan GC, Cai L, Elowitz M, et al. (2017) Challenges and emerging directions in single-cell analysis. Genome Biol 18: 84. doi: 10.1186/s13059-017-1218-y
    [131] Hayes J, Thygesen H, Tumilson C, et al. (2015) Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature. Mol Oncol 9: 704-714. doi: 10.1016/j.molonc.2014.11.004
    [132] Goldstein LD, Chen YJJ, Dunne J, et al. (2017) Massively parallel nanowell-based single-cell gene expression profiling. BMC Genomics 18: 519. doi: 10.1186/s12864-017-3893-1
    [133] Aytes A, Mitrofanova A, Lefebvre C, et al. (2014) Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy. Cancer Cell 25: 638-651. doi: 10.1016/j.ccr.2014.03.017
    [134] Peyer KE, Zhang L, Nelson BJ (2013) Bio-inspired magnetic swimming microrobots for biomedical applications. Nanoscale 5: 1259-1272. doi: 10.1039/C2NR32554C
    [135] Yamanaka YJ, Szeto GL, Gierahn TM, et al. (2012) Cellular Barcodes for Efficiently Profiling Single-Cell Secretory Responses by Microengraving. Anal Chem 84: 10531-10536. doi: 10.1021/ac302264q
    [136] Song R, Acar M (2019) Stochastic modeling of aging cells reveals how damage accumulation, repair, and cell-division asymmetry affect clonal senescence and population fitness. BMC Bioinformatics 20: 391. doi: 10.1186/s12859-019-2921-3
    [137] Bressloff PC, Newby JM (2013) Stochastic models of intracellular transport. Rev Mod Phys 85: 135-196. doi: 10.1103/RevModPhys.85.135
    [138] Ribeiro RDC, Pal D, Jamieson D, et al. (2017) Temporary Single-Cell Coating for Bioprocessing with a Cationic Polymer. ACS Appl Mater Interfaces 9: 12967-12974. doi: 10.1021/acsami.6b16434
    [139] Kharchenko PV, Silberstein L, Scadden DT (2014) Bayesian approach to single-cell differential expression analysis. Nat Methods 11: 740-742. doi: 10.1038/nmeth.2967
  • This article has been cited by:

    1. Krzysztof Psiuk-Maksymowicz, 2024, Chapter 17, 978-3-031-38429-5, 215, 10.1007/978-3-031-38430-1_17
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6322) PDF downloads(616) Cited by(2)

Article outline

Figures and Tables

Figures(3)  /  Tables(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog